Joint Fellowship Training Program Mentors Robert Ball, MD, MPH, Kathryn O'Connell, MD, PhD, Robert Wise, MD, MPH Medical Officers, Division of Epidemiology, Office of Biostatistics and Epidemiology (OBE/DE), Center for Biologics Evaluation and Research (CBER), FDA kathryn.oconnell@fda.hhs.gov Brian Booth Acting Team Leader Clinical Pharmacology, Division of Oncology Drug Products (DODP), Center for Drug Evaluation and Research (CDER), FDA brian.booth@fda.hhs.gov Peter Bross, M.D. Clinical Oncology Reviewer and Team Leader Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), FDA peter.bross@fda.hhs.gov Ramzi Dagher, MD Medical Team Leader, Office of Oncology Drug Products (OODP), Center for Drug Evaluation and Research (CDER), FDA ramzi.dagher@fda.hhs.gov Mary A. Foulkes, Ph.D., M.P.H. Office of Biostatistics and Epidemiology, CBER Foulkes@cber.fda.gov Steven Hirschfeld, M.D., Ph.D. Medical Officer, Toxicology, Division of Clinical Evaluation and Pharmacology (DCEPT), Office of Cellular Tissue and Gene Therapies (OCTGT) Center for Biologics Evaluation and Research (CBER), FDA steven.hirschfeld@fda.hhs.gov Robert Justice, MD Director, Division of Drug Oncology Products, Office of Oncology Drug Products, Office of New Drugs, CDER robert.justice@fda.hhs.gov John Leighton, PhD Supervisory Pharmacologist, Division of Drug Oncology Products, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Research and Evaluation (CDER), FDA john.leighton@fda.hhs.gov Ke Liu, MD, PhD Medical Officer and Clinical Oncology Reviewer, Office of Cellular, Tissue and Gene Therapies (OCTGT), Center for Biologics Evaluation and Research (CBER), FDA robert.ke.liu@fda.hhs.gov Diane Mitchell, M.D. Medical Officer; Office of Device Evaluation, Center for Devices and Radiological Health (CDRH), FDA diane.mitchell@fda.hhs.gov Mercedes Serabian, M.S, DABT FDA, Center for Biologics Evaluation and Research (CBER), Office of Cellular, Tissue and Gene Therapies (OCTGT) mercedes.serabian@fda.hhs.gov

Home   |   Privacy Notice   |   Accessibility